A Geopolitical, Legal, and Public-Health Crisis-and Why MMJ International Holdings Offers a Viable Federal Solution

"President Trump is facing an impossible landscape created by years of regulatory neglect. We built a federally compliant, pharmaceutical grade marijuana medicine to bring order to that chaos. MMJ offers the President a path that respects the law, protects patients, and restores integrity to cannabinoid science."

-Duane Boise, President & CEO, MMJ International Holdings

WASHINGTON, DC / ACCESS Newswire / December 2, 2025 / President Donald Trump now faces one of the most complex drug-policy decisions in modern American history: whether to reschedule marijuana under the Controlled Substances Act (CSA).

While industry lobbyists portray rescheduling as a simple politica

See Full Page